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Biochemistry and I were born and grew at about the same time, Before the 
tum of the century some organic chemists and physiologists had lain the 
bases of Biochemistry, In 1906 two journals dealing with it appeared, the 
Biochemische Zeitschrift and the Biochemical Journal, The Journal of Bio­
logical Chemistry had started publication only one year before, In 1906 
Arthur Harden and W, J, Young were able to separate "yeast juice into a 
residue and filtrate, each of which was itself incapable of setting up the 
alcoholic fermentation of glucose, whereas, when they were reunited the 
mixture produced almost as active fermentation as the original juice," This 
finding occurred only nine years after Edward Buchner had prepared a cell 
free yeast juice capable of fermentation, This line of work led eventually to 
the discovery of the multitude of enzymes, coenzymes, and intermediates 
of cell metabolism, In 1906 Tswett published the first description of 
chromatography, 
Another important event (from my point of view) occurred in 1906, This 
was my birth in Paris, 81 Avenue Victor Hugo,just a few blocks away from 
the Arc de Triomphe, 
The growth of Biochemistry was rapid; in a few decades most of the 











































































time of writing this essay it is showing signs of dismemberment. Molecular 
Biology, Cell Biology, Chemical Genetics, etc have risen from it and surely 
there will be others. I reached the age of 76 thanks to some clever arterial 
repair work carried out by Michael Debakey in Houston. 
I have borrowed the title of this essay from a delightful book by W. H. 
Hudson ( 1) that describes the wild life in the country near Buenos Aires. 
Hudson describes the same scenery and the same animals, flamingoes, 
armadillos, caranchos, vizcachas, etc that I saw in my infancy. It seems that 
both of us were interested in animal life and understanding nature, but while 
I became convinced that scientific knowledge and technology would be 
good for mankind, Hudson (2) had some doubts and he expressed them as 
follows: "Ah yes, we are all seeking after happiness in the wrong way. It 
was with us once, and ours, but we despised it, for it was only the old 
common happiness which Nature gives to all her children, and we went 
away from it in search of another grander kind of happiness, which some 
dreamer-Bacon or another-assured us we would find. We had only to 
conquer Nature, but how weary and sad we are getting!! The old joy in life 
and gaiety of heart have vanished." 
B. A. HOUSSA Y'S INSTITUTE OF PHYSIOLOGY 
When I was two years old my Argentine parents brought me to Buenos 
Aires, where, after going through the studies and examinations necessary 
for graduating as an M.D. at the University of Buenos Aires in 1932, I 
worked at the Hospital of the University (Hospital de Clinicas) for about 
two years. I was never satisfied with what we did for the patients. Looking 
back on those times, I realize how profoundly medicine has changed since 
then. Medical treatment was in those days only slightly better than that 
exemplified by the French story, in which the doctor ordered, "Today we 
shall bleed all those on the left side of the ward and give a purgative to all 
those on the right side." 
When I practiced medicine, except for surgery, digitalis, and a few other 
active remedies, we could do little for our patients. Antibiotics, psychoac­
tive drugs, and all the new therapeutic agents were unknown. It was there­
fore not strange in 1932 that a young doctor such as I should try to join 
efforts with those who were trying to advance medical knowledge. The most 
active research laboratory in town was that directed by Dr. Bernardo A. 
Houssay, professor of physiology. In his work on the role of the pituitary 
gland on carbohydrate metabolism, he obtained some very novel findings, 
for which he, along with Carl and Gerty Cori, was awarded the Nobel Prize 
in Physiology and Medicine in 1947. Dr. Houssay suggested that I could 
do my thesis work under his direction and proposed several topics. My 









































































FAR AWAY AND LONG AGO 3 
task was to learn how to measure blood sugar with the method of Hagedorn 
& Jensen. It was my first experience in a research laboratory. My ignorance 
in chemistry was unfathomable; for that reason I decided to follow some 
courses in the Faculty of Sciences. 
Houssay helped me a lot. Not only did he do the brain work but he also 
carried out most of the adrenalectomies on the dogs. Houssay made daily 
rounds in the Institute and often left messages on minute pieces of paper. 
It was apparently through him that I learned to be economical. Even now, 
I usually write manuscripts on half sheets of paper already used on one side. 
Young people now are spendthrifts and would scandalize Houssay as they 
do me. The thesis work was awarded the Annual Prize of the Faculty for 
the best thesis, but it was undoubtedly Houssay's merit, not mine. Our close 
association lasted until Dr. Houssay's death in 1970. During all those years 
we saw each other daily and I could appreciate his cyclopean work in favor 
of Argentine science. 
My enthusiasm for research increased gradually and, without noticing 
the change, I began to put in more hours at the laboratory and less at the 
hospital. I could do so because I did not have to earn my living with medical 
work. My great-grandparents came to Argentina, some from France, others 
from Spain, and bought land when it was cheap but still unsafe from the 
incursions of the Indians. Later these lands produced the cereal and grains 
and the cattle that brought riches to the country and to the pioneers who 
worked on them. These circumstances allowed me to devote myself to 
research when it was very difficult or impossible to find a full-time position 
for research. 
It was a great privilege to be associated with Houssay. He worked very 
hard all his life trying to modernize the teaching of medicine, as well as 
directing his numerous students. His interest in research was very wide. 
Endocrinology was his main concern but he also ventured into many other 
aspects of physiology and biochemistry. He made intensive efforts to pro­
mote science. He was for many years president of the Argentine Association 
for the Progress of Science and later president of the Argentine Research 
Council. At times his efforts were very successful, but at other times the 
government was against him because of his outspoken manner and his 
liberal views. 
INITIATION IN BIOCHEMISTRY (3) 
After I finished my thesis work, Dr. Houssay advised me to work some time 
abroad. In consultation, with Dr. V. Deulofeu, professor of biochemistry, 
and Dr. R. de Meio, I decided that a good place would be the Biochemical 
Laboratory of Cambridge University, directed by Sir Frederick Gowland 










































































for "his discovery of growth stimulating vitamins." Cambridge was then at 
the peak of its glory with Rutherford, Dirac, and other scientific giants in 
the Department of Physics. Biochemistry was also excellent with Hopkins, 
the father of English Biochemistry, at the helm of the biochemical labora­
tory, and David KeiIin, the discoverer of the cytochromes, in the Depart­
ment of Parasitology. Arriving in Cambridge thirsty for knowledge, I began 
immediately to work under the direction of Malcolm Dixon on the effect 
of cyanide and pyrophosphate on succinic acid dehydrogenase. After that 
I worked with Norman L. Edson on ketogenesis using liver slices. Edson 
had worked with Hans Krebs, whom he admired greatly. When Edson 
returned to his home country, New Zealand, I worked with David Green 
on the purification and properties of ,B-hydroxybutyrate dehydrogenase. 
The atmosphere in the biochemical laboratory was very stimulating because 
of the many talented people there, such as Marjorie Stephenson, one of the 
pioneers in bacterial biochemistry, Norman Pirie, who had crystallized 
tobacco mosaic virus, Robin Hill, who was well known for his work on 
photosynthesis (the Hill effect), Joseph Needham, who started chemical 
embryology and ended up as an orientalist, Dorothy Moyle Needham, an 
expert in muscle chemistry, and many others. 
FATTY ACIDS (3, 4) 
After my year at Cambridge, I returned to the Institute of Physiology in 
Buenos Aires, where I became associated with J. M. Munoz. I never enjoyed 
working by myself so I was glad I could work with him. He had a rather 
original personality, and degrees in Medicine and Chemistry. Not content 
with these titles, he also earned a degree in Dentistry. Actually he did so 
not merely to increase his knowledge, but more importantly in order to 
become the professor of physiology in the school of dentistry. That type of 
ludicrous requirement was not too rare at our university. As a way to avoid 
competition from other graduates, it was of course detrimental to the 
university and the students. 
Dr. Munoz had been estimating ethanol, and had a reliable method with 
a beautiful, small distillation apparatus. Therefore we decided to work on 
ethanol metabolism, with interesting results that were published in the 
Biochemical J ouma/. 
After our alcoholic adventure we took advantage of the same distillation 
apparatus for estimating volatile fatty acids. Munoz found that the recovery 
was quantitative if the boiling point of the samples was increased by the 
addition of sodium sulfate. The volatile fatty acids (butyric acid was gener­
ally used) were then measured by oxidation with dichromate. 
After working with tissue slices, we turned our attention to tissue homo­









































































FAR AWAY AND LONG AGO 5 
to occur only in intact cells. Our approach was different from previous ones 
because we planned to measure fatty acid disappearance while other work­
ers had relied on measurements of oxygen uptake with or without fatty 
acids. We obtained some homogenates that consumed butyric acid, but in 
general our experiments failed. Learning from our failures, we managed to 
find conditions under which our liver homogenates were active. It was a 
question mostly of working fast and in the cold. Because we wanted to 
fractionate the extracts, we had to cool our centrifuge. We did this with an 
automobile inner tube filled with freezing mixture and wrapped around the 
head of an old pulley-driven centrifuge. In this way we were able to separate 
a cell free particulate fraction and a supernatant fluid. The particulate 
fraction was found to require several factors for oxidizing fatty acids. These 
factors were cytochrome C, a C4 dicarboxylic acid (we usually used fumaric 
acid) and adenosin phosphate (ATP was active but we used adenylic acid 
because it was easier to obtain the pure substance). We suspected that 
mitochondria were involved in fatty acid oxidation but could not prove it. 
In those days mitochondria were known to cytologists but practically un· 
known to biochemists. Claude had just started centrifugal fractionation 
and separated tissue homogenates into fractions containing mainly nuclei, 
mitochondria, or smaller constituents (micro somes). 
AN ADVENTURE IN HYPERTENSION (5, 6, 7) 
While we were working with Dr. Munoz on fatty acid oxidation, J. C. 
Fasciolo was experimenting on the mechanism of renal hypertension. Un­
der Houssay's guidance, he followed the discovery of Harry Golblatt, 
who had found that if the renal artery of dogs was mechanically constricted 
the animals developed a permanent hypertension. This had been a milestone 
because it provided an experimental method of producing high blood pres­
sure. Fasciolo's contribution consisted in grafting one of those kidneys in 
a normal dog and observing the changes in blood pressure. The result was 
an increase in blood pressure, which proved that the effect was due to some 
substance that the constricted kidney poured into the blood. At that stage, 
I became involved. Dr. J. C. Fasciolo, E. Braun Menendez, J. M. Munoz, 
and I formed a team that successfully clarified the problem. Dr. A. Taquini 
also collaborated in many experiments. 
An early observation was that from the blood of the constricted kidney 
a substance that produced a transient rise in blood pressure could be ex­
tracted with acetone. The effect did not last as long as that produced by 
grafting a constricted kidney. In 1898 Tigersted & Bergman had discovered 
a pressor substance they called renin, which could be extracted from kid­
neys. We found that the effect of renin was clearly different from that 










































































We then carried out a variety of experiments to obtain the in vitro produc­
tion of the pressor substance. Incubations of kidney extracts or slices with 
blood plasma under aerobic or anaerobic atmosphere yielded only inactive 
extracts. One day Dr. Braun Menendez suggested that I should incubate 
renin with blood plasma. I told him I had incubated kidney extracts that 
contained renin with blood with negative results. I said I had done this 
experiment many times but that if it made him happy I might test renin. 
The incubation gave rise to the formation of a pressor substance soluble in 
aqueous acetone; we soon found that the properties were the same as those 
of the pressor compound found in the constricted kidney blood. We worked 
feverishly and obtained in a short time much information on the new 
substance, which we called hypertensin. We suggested that renin acted as 
an enzyme and released hypertensin from a precursor found in blood 
plasma. We also detected an enzyme in tissues and blood that destroyed 
hypertensin; this explained my previous failure to detect hypertensin forma­
tion. If the incubation time was too long or the destroying enzyme too 
active, all the hypertensin formed would disappear. The action of renin was 
found to have an interesting specificity, thus dog renin acted on dog serum, 
human renin on human serum, and so on, but they did not cross-react. 
While we were working busily in Buenos Aires, others were conducting 
similar experiments elsewhere. In the laboratories of Eli Lilly in Indianapo­
lis, Irwin Page and co-workers observed that purified renin showed pressor 
activity when injected into the blood but was inactive as a vasoconstrictor 
when tested on a dog's tail perfused with Ringer solution. They suggested 
that renin required a blood protein as activator. In fact they found that 
addition of blood plasma restored vasoconstrictor activity. Page et al 
proposed the name angiotensin for what we used to call hypertensin. Al­
though our paper was already published ( 1939) when we learned of the 
work of the other group we were considerably depressed because we could 
not claim a discovery but only a co-discovery. Looking back now after so 
many years I view those feelings as quite infantile. However, such incidents 
happen quite often in research, and they affect workers even more experi­
enced than we were at that time. 
For several years, both groups tried to impose the names they had 
proposed. We used the terms hypertensin, hypertensinogen and hypertensi­
nase, while the Indianapolis group referred to angiotensin and renin activa­
tor. Finally Dr. Braun Menendez and Page agreed on a Solomonic solution 
and proposed the names angiotensin and angiotensinogen. These are the 
names generally used today. 
The purification and determination of the structure of angiotensin seemed 
an insurmountable problem in those days. We knew it was a polypeptide 
because it became inactive on treatment with proteolytic enzymes but the 









































































FAR AWAY AND LONG AGO 7 
the sequence of a polypeptide was conceived only by stretching a wild 
dream. 
It is now known that renin splits a leucyl-leucyl bond in angiotensinogen 
to yield the decapeptide angiotensin I, which is inactive, but when acted 
upon by a converting enzyme, it loses the dipeptide histidyl-Ieucine to yield 
angiotensin II, which is very active. The latter peptide may lose an aspartic 
acid residue to yield angiotensin III, which is less active than II. Much was 
accomplished after we abandoned the problem. The great advances came 
possibly because of the progress of the methods for amino acid analysis and 
peptide synthesis. 
My incursion in hypertension research lasted only about one year but it 
was one of the most productive years in my career. Two important factors 
in the success were the congenial atmosphere and the personal quality of 
my teammates. They had very different personalities but worked together 
successfully. E. Braun Menendez was full of energy, enthusiasm and entre­
preneurial ability; J. Munoz had a very original personality and many 
unique ideas; good-humored Juan Carlos Fasciolo always told jokes or 
funny stories, but he also performed his work seriously, intelligently and 
efficiently. All were very clever and diligent. We had quite a lot of f un with 
our work. After successful experiments, I often said "You see, nothing can 
resist systematic research." But after failed experiments, I looked tired and 
depressed, so Dr. Fasciolo would make fun of me, saying "You see, nobody 
can resist systematic research." However, we worked hard; the rate of 
research was limited only by the availability of dogs for measuring pressor 
substances. We also used toads for measuring vasoconstrictor substances 
but with little success. They always gave confusing results. 
A STAY IN U.S.A. (3) 
Our work in the Institute of Physiology was interrupted in 1943 by unex­
pected and disagreeable events. Dr. Houssay never mixed up in politics but 
had signed an apparently innocent letter that appeared in the newspapers 
and also carried the signature of many of the most important persons of the 
country. The letter asked for "constitutional normality, effective democ­
racy, and American solidarity." The government reacted completely out of 
proportion, and decreed the dismissal of all the signers who had positions 
in the state institutions. Many of the best university professors lost their 
posts. Dr. Houssay was one of them. Most of the members of the Institute 
of Physiology resigned in protest and disbanded. Days of confusion and 
preoccupation followed. It was finally decided to continue working, not in 
the university but in a private institution that had to be organized from 
scratch. Since I was always in a hurry to do experiments and not lose time, 










































































decision coincided with an important and fortunate event in my life, the 
start of a happy marriage. My wife and I decided to travel to the United 
States. Commercial planes were still two-motored and flew only by day; 
thus after several stops in various parts of the American continent, we 
finally arrived in New York. Since I had no previous arrangements, I had 
to look for a place in which to work. One place that was highly regarded 
then was Cori's laboratory in St. Louis. The Coris had just published a 
thorough and careful study on the crystallization and preparation of phos­
phorylase. 
After looking around a few days in New York we traveled to St. Louis, 
where Carl Cori accepted me kindly in the laboratory. There he arranged 
that l should collaborate with Ed Hunter on the formation of citric acid. 
Thus for six months I had the privilege of working in a place full of 
traditions, where I met daily with Carl and Gerty Cori, Sidney Colowick, 
Arda Green, and other outstanding scientists. To broaden my outlook, I 
spent time in New York, where I arranged to work again with David E. 
Green. He had two rooms in the College of Physicians and Surgeons of 
Columbia University, and a small group of collaborators including Sarah 
Ratner, Eugene Knox, and Paul Stumpf. For some time we worked on the 
purification of aminotransferases and we were able to separate the alanine 
from the aspartate-aminotransferase. Green was always full of ideas and 
sometimes 'came in with a list of all the processes that had to be clarified. 
The list was impressive but I did not know how to attack any of those 
problems. When I told him about the fatty acid oxidation system that 
needed so many co-factors and that might be localized in mitochondria, he 
looked at me with a rather incredulous smile. He did not suspect then that 
these organelles would occupy a great part of his future. 
One of the important things I learned from Green was that if one could 
find a place to work, one should be able to form a research group by asking 
around for the required salaries, equipment, and chemicals. Indeed, that 
was just what I did upon returning to Argentina, where I formed a small 
research group that grew slowly and gave rise to the Fundacion Campomar. 
FUNDACION CAMPOMAR (3, 8, 9, 10, 11) 
After my stay in the United States, I returned to the Institute of Physiology. 
Dr. Houssay had been reinstated and was trying to put the Institute to­
gether again. For some time I worked by myself and endeavored to start 
a small research team. The first perso
'
n I attracted was Dr. Ranwel Caputto 
of the University of Cordoba, who had just returned from the Biochemical 
Laboratory in Cambridge. He had worked with Malcolm Dixon, and had 
succeeded in crystallizing glyceraldehyde dehydrogenase. Later he found 









































































FAR AWAY AND LONG AGO 9 
probably the natural substrate. The second to join the group was microbi­
ologist Raul Trucco. The idea in selecting him was to continue the work 
on fatty acid oxidation but with bacterial enzymes. 
I learned in 1946 that Dr. Houssay had been approached by Jaime 
Campomar, one of the owners of an important textile industry. Campomar 
wanted to finance a research institution specializing in biochemistry. I 
suspect that there were few candidates for director of the new institution; 
thus, even though Dr. Houssay may not have been very convinced that I 
could be successful in the enterprise, he suggested me. 
As things were being organized, we continued to work in a cellar in the 
faculty of medicine, but only until Dr. Houssay was again removed from 
his position as professor of physiology and director of the Institute of 
Physiology, on the pretext that he was overage. This new abuse produced 
a great commotion in the faculty and most of us decided to leave. If the 
installations and equipment were poor at the faculty, they were disastrous 
in the laboratory into which we moved. This was the Instituto de Biologia 
y Medicina Experimental, a private institution that had been created when 
Dr. Houssay was first dismissed from the university. Shortly afterwards we 
rented a small, four-room house beside the above mentioned institute and 
adapted it for our laboratory. Others joined the group then, including 
Carlos Cardini, who had been for several years professor at the University 
of Tucuman, N. Mittelman, who had good training in protein fractionation, 
and A. C. Paladini, the youngest of all, who joined us with a fellowship. Mr. 
Campomar's annual contribution of 100,000 Argentine pesos was equiva­
lent to about US $25,000. It was a very generous gift. With it we installed 
the laboratory, acquired some equipment, and paid some salaries. 
After several false starts we happened to step into a field that turned out 
to be rather fertile. Dr. Caputto had told us that he had done some experi­
ments that indicated that mammary gland homogenates produced lactose 
when incubated with glycogen. This seemed an interesting finding because 
the biosynthesis of saccharides was a rather unexplored field. At that time 
the only disaccharide that had been synthesized in vitro was sucrose. The 
enzyme used was of bacterial origin and the reactants were glucose 1-
phosphate and fructose. We carried out many experiments with the mam­
mary gland extracts but they gave generally ambiguous results, mainly 
because we used only very primitive methods for lactose detection, such as 
osazone formation. Discouraged, we thought of another approach-to find 
an enzyme that would catalyze the reversible synthesis of lactose. For this 
purpose we obtained a culture of Saccharomyces fragilis, a yeast that uti­
lizes lactose. With this yeast it was found that oxygen uptake was faster 
when lactose was the substrate than with a mixture of glucose and galactose. 
At first we thought we would find some direct pathway for lactose utiliza­










































































permeability, but we never investigated the point exhaustively. We did find 
a very active lactase and therefore directed our attention to galactose utili­
zation. We obtained evidence indicating that galactose was phosphorylated 
and therefore the corresponding enzyme was studied. The reaction product 
was found to be galactose I-phosphate and the study of its utilization led 
us to the detection of glucose 1, 6-diphosphate and uridine diphosphate 
glucose. We prepared glucose I-phosphate and galactose I-phosphate by 
chemical synthesis and observed that they were utilized when we incubated 
them with enzymes from galactose-adapted yeast. The disappearance was 
increased by the addition of a heated yeast extract. At first we thought that 
there was only one factor in the heated extract that activated the reactions 
with the two esters but after more work and many confusing experiments 
we realized that two thermostable factors were involved. One was necessary 
for the conversion of galactose I-phosphate into glucose I-phosphate, which 
requires the inversion, of the hydroxyl group at carbon four. The other 
cofactor was required for the formation of glucose 6-phosphate from glU­
cose I-phosphate, that is, a change of position of the phosphate group. 
Quantitative methods of estimating each of the two co-factors with the 
appropriate enzymes could be developed, and the next step was to purify 
the active substances. This was not as easy as it is now with all the current 
methods of fractionation. The procedures then available consisted of the 
separation of the barium, calcium, or mercury salts. 
The co-factor of the phospho-glucomutase reaction had properties simi­
lar to those of fructose 1, 6-diphosphate; in fact, our partially purified 
preparations were enriched in it, but it was possible to destroy the fructose 
ester, leaving the active substance intact. Finally the co-factor was obtained 
pure, which turned out to be glucose 1, 6-diphosphate. 
Studies on the other co-factor were also advancing. Purification by frac­
tionation of the mercury salts and charcoal adsorption had yielded concen­
trates that adsorbed light at 260 nm. The spectrum was similar to that of 
adenosine but had some differences. For quite some time we were unable 
to discover the identity of the 260 nm absorbing substance until Dr. Caputto 
came in one morning with the last issue of the Journal of Biological Chemis­
try and showed us a spectrum identical to ours. This spectrum was that of 
uridine. Things became easier because we could measure the substance with 
a spectrophotometer instead of the enzymatic tests. 
In addition to uri dine the co-factor was found to contain glucose and two 
phosphates. Identification of the glucose waS carried out by paper chroma­
tography, a technique that we had just started to use. We employed a very 
inadequate solvent, but the results were correct. Only later were good 
solvents for sugar separations described. The presence of uridine in a co­









































































FAR AWAY AND LONG AGO 1 1  
the nucleoside present was adenosine. The occurrence of a sugar derivative 
combined with a nucleoside was also noveL The mechanism of action of 
uridine diphosphate glucose (UDPG) began to become clear when we found 
that the enzyme preparations active in converting galactose I-phosphate 
into glucose I-phosphate could also convert reversibly the glucose moiety 
of UDPG into galactose. Later Kalckar and coworkers found that NAD 
was necessary in this reaction; it  seemed likely that the inversion of hy­
droxyl four occurred by an oxidoreduction reaction. 
Dr. Paladini detected a new compound similar to UDPG by applying 
paper chromatography to yeast extracts. When very alkaline solvents were 
used, the sugar moiety of UDPG became separated from the nucleotide as 
could be ascertained by the noncoincidence of ultraviolet absorption and 
the color given by reagents for sugar detection. The products of de­
composition were identified as uridine Sf-phosphate and cyclic glucosel,  2-
monophosphate. Besides this compound, crude preparations of UDPG 
gave another substance that was not decomposed in alkaline solvents. It 
seemed the same as UDPG but with a different sugar moiety. This 
substance turned out to be uridine diphosphate acetylglucosamine. Since it 
has no hydroxyl group at position 2 of the sugar, it cannot form a cyclic 
phosphate. At about the same time James Park discovered other uridine 
nucleotides containing acetylmuramic acid plus some amino acids that are 
now known to be intermediates in the formation of peptidoglycan, a 
component of the cell walls of bacteria. 
Paper chromatography of crude UDPG preparations allowed us to detect 
still another sugar nucleotide. The guanosine moiety could be identified 
easily because of its typical ultraviolet spectrum with a peak at 260 nm and 
a shoulder at 280 nm. It was studied mostly by Dr. Enrico Cabib, a bright 
young man who had joined our team as a fellow replacing Paladini, who 
had gone to work with L. Craig at the Rockefeller Foundation in New 
York. He had a good sense of humor and was a hard worker. Except for 
minor episodes that occur in all human groups, the atmosphere in the 
laboratory was very pleasant and all our time was dedicated to research. We 
had no lectures to give, no committees, and no forces pulling us away from 
the laboratory. 
In 1957, Mr. Campomar's death left our institute without resources. 
Before disbanding we played our last card and asked for a grant from the 
National Institute of Health of the United States. We had little hopes of 
success, but to our surprise the grant was approved, and we continued our 
work. 
To detect any unknown reaction involving UDPG, we used the same 
method of estimation that we had used for developing the isolation proce­










































































I-phosphate-glucose I-phosphate transformation. We used this method in 
experiments with yeast extracts with various additions and found that 
glucose-6-phosphate produced an increase in UDPG disappearance. With 
Dr. Cabib we traced the effect to the synthesis of trehalose-6-phosphate, an 
ester that W. T. Morgan had isolated several years earlier as a product of 
the action of yeast enzymes. 
A similar procedure with wheat germ enzymes allowed us, with C. Car­
dini and J. Chiriboga, to detect the biosynthesis of sucrose. In the course 
of studies on the later process, we detected another enzyme that makes 
sucrose phosphate. 
Hexosamine metabolism was the object of considerable research. We 
became interested in this field because of the discovery of UDP-acetyl­
glucosamine. We wanted to find a role for this compound. One obvious role 
was the formation of acetylgalactosamine made likely by H. Pontis, who 
isolated UDP-acetylgalactosamine from liVer. Another function of UDP­
acetylglucosamine that seemed obvious was the formation of chitin. In fact, 
years later L. Glaser obtained a transfer of acetylglucosamine to chitin. 
With C. Cardini we studied the formation of glucosamine phosphate from 
glutamine and hexosephosphate. 
In 1957 we entered another field. It was found that liver extracts could 
catalyze the formation of glycogen from UDPG. In those days it was firmly 
believed that glycogen was formed from glucose I-phosphate. However 
some penetrating minds had expressed doubts about this. For instance Earl 
Sutherland had reasoned that it was difficult to understand why epineph­
rine, which activated glycogen phosphorylase in vitro, should always pro­
duce glycogenolysis in vivo. Herman Niemeyer went further and suggested 
that glycogen was formed not from glucose-I-phosphate but from UDP­
glucose. Our finding was therefore not totally unexpected but nevertheless 
helped considerably in the clarification of the mechanism of glycogen syn­
thesis and degradation. Soon after, we detected the activating effect of 
glucose-6-phosphate, a finding which gave new impetus to the work on 
regulation of glycogen metabolism. The studies on glycogen synthetase were 
carried out with C. Cardini, H. Carminatti, S. Goldemberg and J. M. 
Olavarria. In 1958 the government offered us a large house which had been 
a girls' school, where we are still working. Funds were scarce, so we moved 
into the new house after minimal adaptation. A short time thereafter the 
National Research Council was created and we became associated with the 
faculty of sciences of the University of Buenos Aires. As new workers joined 
the laboratory, it lost the romantic flavor it used to have. 
Research on glycogen biosynthesis was extended to include starch. It 
seemed obvious that the synthetic mechanism should be the same or very 









































































FAR AWAY AND LONG AGO 13 
we detected activity in transferring glucose from UDPG in some starch 
grains. The activity seemed low and we reasoned it might be because we 
used the wrong substrate. G. Khorana had then developed rather simple 
chemical methods for the synthesis of sugar nucleotides. We attracted a new 
collaborator, trained in organic chemistry, Dr. E. Recondo. The idea, which 
at times seemed quite silly, was to synthesize nucleotides of glucose and 
different bases, and to test them with the starch enzyme. The most available 
starting materials were AMP and glucose I-phosphate, so Dr. Recondo 
synthesized ADPG first. The enzymatic tests showed that this sugar nucleo­
tide was active as donor and better than UDPG. We were not sure that the 
result was not an artifact until Dr. J. Espada detected in plant material an 
enzyme that led to the synthesis of ADPG. Later other workers found that 
it was the substrate for glycogen synthesis in bacteria. 
Another aspect of glycogen synthesis which interested us and Dr. J. 
Mordoh, A. J. Parodi and C. Krisman was the high molecular weight 
glycogen that can be extracted from tissues by avoiding treatment with acid 
or alkali. These preparations have molecular weights ranging from 10 to 
1,000 million daltons and give a characteristic aspect on examination with 
the electron microscope. Similar preparations could be obtained in vitro 
with glycogen synthetase and UDPG but not with glycogen phosphorylase 
working in the synthetic direction. The make up of high molecular weight 
glycogen still remains rather mysterious. 
DOLICHOL DERIVATIVES (12, 13, 14) 
In 1965 a rather important development in the field of polysaccharide 
biosynthesis was the simultaneous discovery of lipid intermediates by two 
groups of workers: P. Robbins et al in Boston, who were investigating the 
biosynthesis of lipopolysaccharides by Salmonella, and J. Strominger in 
Madison, who was working on the formation of the cell wall peptidoglycan 
in Staphylococcus. Both groups detected the formation of liposoluble inter­
mediates identified as polyprenyl phosphate-sugars. Our colleague Marcelo 
Dankert, who worked in Dr. Robbins' group, returned to our laboratory 
and told us about these compounds. He was very enthusiastic about the new 
field. We happened to have some crude preparations of glycogen synthetase, 
and radioactive UDPG was always easy to find around the laboratory. With 
N. Behrens we mixed these two substances, incubated them, added n­
butanol, as Dankert taught us, separated the organic phase, and counted its 
radioactivity. The incubated sample had only a few counts more than the 
control. The experiment was repeated with the same results, but after 
optimizing the conditions, we obtained a considerable incorporation of 










































































The next advance was the detection of an activation of the reaction by 
some liver extracts. In contrast to our previous work, in which water soluble 
substances were involved, the activator was soluble in certain organic sol­
vents. We purified wnsiderably the activating substance of liver extracts, 
but we could not obtain the amounts necessary for analysis. Judging from 
properties of the substance it seemed that a polyprenol phosphate was a 
good bet. Therefore dolichol, a 20-isoprene unit, saturated polyprenol 
present in liver, was isolated and phosphorylated chemically. The reaction 
product was active as an acceptor of glucose and had the same properties 
as the activating substance of liver. It was concluded therefore that the 
reaction product was dolichol-phosphate-glucose. 
Here we had a new compound of unknown function that might be an 
artifact. Finding a role for it was not easy. Quite a lot of time was spent in 
trying to find out if it had a role in collagen synthesis, since this is the only 
glycoprotein that contains glucose. The results were negative. By chance it 
was found that dolichol-phosphate-glucose disappeared when incubated 
with liver extracts and that a new substance was formed. The role of this 
new substance remained rather mysterious until it was observed that it 
could be dissolved in chloroform-methanol-water 1 : 1 : 0.3. Mixtures of the 
same solvents in other proportions did not solubilize it. This was a small 
but important finding. Once the right solvent was found, the new substance 
could be fractionated on anion exchange columns and thus obtained pure. 
It was decomposed by mild acid treatment yielding a lipidic part and 
another hydrophylic part. The water soluble part had the properties of an 
oligosaccharide, which is now known to contain 3 glucoses, 9 mannoses, 
and 2 acetylglucosamine molecules; the lipophylic part appeared to be 
dolichol-diphosphate. The sugar moiety was found to be transferred to 
protein. This part of the work was done in collaboration with A. Parodi, 
R. Staneloni, and H. Carminatti. 
Since then the field has attracted many brilliant investigators and has 
progressed rapidly. 
WHY RESEARCH 
I do not know how it happened that I followed a scientific career. It was 
not a family tradition, because my parents and brothers were involved 
mainly in rural activities. My father had graduated as a lawyer but did not 
practice. In our home there were always a lot of books on the most varied 
subjects and I had the opportunity to acquire information on natural 
phenomena. I suppose the most important factor in determining my future 
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Among the negative abilities I might mention that my musical ear was 
very poor so that I could not become a composer or a musician. In most 
sports I was mediocre so that was another activity that did not attract me 
too much. My lack of oratorical ability closed the door to politics and law. 
I was a bad practising physician because I was never sure of the diagnosis 
or of the treatment. 
These negative conditions were accompanied presumably by others not 
so negative: great curiosity in understanding natural phenomena, normal or 
slightly subnormal capacity for work, average intelligence, and excellent 
capacity for teamwork. Probably the most important thing was my opportu­
nity to spend my days in the laboratory and to do many experiments. Most 
failed but a few succeeded either due to pure good luck or to having made 
the right mistake. 
Nearly 50 years have elapsed since I started to research. These have been 
years of fairly hard work but with many agreeable moments. Research has 
many aspects that make it an attractive venture. One is the intellectual 
pleasure of discovering previously unknown facts. There are also human 
aspects worth mentioning. Some of the most pleasant periods in my career 
were those in which I worked with enthusiastic, clever people who had a 
good sense of humor. The discussion of research problems with such people 
is always a most stimulating experience. 
The less agreeable part of research, the routine work that accompanies 
most experiments, is more than compensated for by the interesting aspects, 
which include meeting and sometimes winning the friendship of people of 
superior intellect from different parts of the world. The balance is clearly 
positive. 
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